Trial
NCT01837797
Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
H. Lundbeck A/S
Collaborators
Otsuka Pharmaceutical Co., Ltd.
Condition
Major Depressive Disorder
Intervention
Placebo
Why stopped
The study was terminated because of recruitment challenges
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-17